The complement system in neurodegenerative diseasesJacqui Nimmo, B. Paul Morgan, Robert A.J. Byrne et al.|Clinical Science|2024Cited by 48
Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer’s disease mouse modelWioleta M. Zelek, B. Paul Morgan, Ryan J. Bevan et al.|Brain|2024Cited by 18
The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humansRobert A.J. Byrne, B. Paul Morgan, Aurora Veteleanu et al.|Brain Behavior and Immunity|2025Cited by 11
C3 and C3a as indicators of complement dysregulation in tauopathies and FTLD-associated disordersLaura Nicholls, Wioleta M. Zelek, Jacqui Nimmo et al.|Immunobiology|2025Cited by 2
Complement is dysregulated in Huntington’s disease in mouse and manJacqui Nimmo, Wioleta M. Zelek, Kyle Fears et al.|Immunobiology|2025Cited by 1